dr. murthy on de-escalation strategies in her2-positive breast cancer
Published 6 years ago • 1K plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
0:37
copy of dr. murthy on de-escalation strategies in her2-positive breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
1:27
dr. murthy on future of tucatinib in her2 breast cancer
-
1:47
dr. chien on de-escalation strategies for patients with her2-positive breast cancer
-
1:54
dr. murthy on her2climb trial results in her2 breast cancer
-
17:53
dr. murthy on the clinical implications of tucatinib approval in her2 breast cancer
-
1:46
dr. murthy on caveats of the persephone trial in breast cancer
-
1:27
dr. hurvitz discusses de-escalation in her2 breast cancer
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis
-
1:27
next steps in breast cancer: de-escalation & immunotherapy
-
32:12
education session: "escalating and de-escalation - titrating the right regimen in early stage"
-
8:49
case study: treating her2-positive metastatic breast cancer, part i
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
1:33
dr. mccann on ongoing research in her2-positive breast cancer
-
2:09
adjuvant therapy data for her2-positive breast cancer
-
20:19
masterclass on managing her2 positive breast cancer
-
1:10
dr. janni on the future of treatments for her2-positive breast cancer
-
6:29
her2 early-stage breast cancer
-
1:17
dr. chien on treatment duration in her2 breast cancer